Displaying drugs 6801 - 6825 of 9802 in total
Zenocutuzumab
Zenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).
Investigational
Cinnamic acid
Investigational
Methyl red
Experimental
EHP-102
Investigational
fb-PMT
Investigational
Diglyme
Experimental
Fisetin
Experimental
Diethylene glycol diethyl ether
Experimental
Myristalkonium
Experimental
Hemicellulase
Experimental
Carbazochrome
Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone . In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity...
Experimental
Withdrawn
Methoxyamine
Investigational
Sinefungin
Sinefungin is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. The proteins that adenosyl-ornithine target include RdmB, modification methylase TaqI, rRNA (adenine-N6-)-methyltransferase, and modification methylase RsrI.
Experimental
Valemetostat
Investigational
Displaying drugs 6801 - 6825 of 9802 in total